ES2038593T3 - Un procedimiento para preparar manosil-aglicona del antibiotico a 40926. - Google Patents

Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.

Info

Publication number
ES2038593T3
ES2038593T3 ES198686117453T ES86117453T ES2038593T3 ES 2038593 T3 ES2038593 T3 ES 2038593T3 ES 198686117453 T ES198686117453 T ES 198686117453T ES 86117453 T ES86117453 T ES 86117453T ES 2038593 T3 ES2038593 T3 ES 2038593T3
Authority
ES
Spain
Prior art keywords
antibiotic
manosil
procedure
aglicone
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198686117453T
Other languages
English (en)
Inventor
Enrico Selva
Pietro Ferrari
Beth P. Goldstein
Giovanni Cassani
Francesco Parenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA filed Critical Gruppo Lepetit SpA
Application granted granted Critical
Publication of ES2038593T3 publication Critical patent/ES2038593T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA NUEVA SUSTANCIA ANTIBIOTICA DENOMINADA MANOSIL AGLUCON DEL ANTIBIOTICO A 40926 Y SUS SALES DE ADICION, UN PROCEDIMIENTO PARA PREPARARLO A PARTIR DEL COMPLEJO ANTIBIOTICO A 40926 O DE UN FACTOR DEL MISMO, Y DE SU EMPLEO EN EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS QUE IMPLICAN MICROORGANISMOS SUSCEPTIBLES A EL.
ES198686117453T 1985-12-30 1986-12-15 Un procedimiento para preparar manosil-aglicona del antibiotico a 40926. Expired - Lifetime ES2038593T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858531846A GB8531846D0 (en) 1985-12-30 1985-12-30 Antibiotic a 40926 mannosyl aglycon

Publications (1)

Publication Number Publication Date
ES2038593T3 true ES2038593T3 (es) 1993-08-01

Family

ID=10590309

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198686117453T Expired - Lifetime ES2038593T3 (es) 1985-12-30 1986-12-15 Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.

Country Status (14)

Country Link
US (1) US4782042A (es)
EP (1) EP0228015B1 (es)
JP (1) JP2514942B2 (es)
KR (2) KR950010460B1 (es)
AT (1) ATE71113T1 (es)
DE (1) DE3683266D1 (es)
DK (1) DK167815B1 (es)
ES (1) ES2038593T3 (es)
GB (1) GB8531846D0 (es)
GR (1) GR3003514T3 (es)
HU (1) HU201099B (es)
IE (1) IE59603B1 (es)
IL (1) IL81105A (es)
ZA (1) ZA869716B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK363587A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Antibiotika og fremstilling heraf under anvendelseaf actinomadura parvosata
GB8621912D0 (en) * 1986-09-11 1986-10-15 Lepetit Spa Increasing ratio of components of anti-biotic complex
GR871488B (en) * 1986-10-10 1987-11-12 Lepetit Spa New antibiotics
DE68925951T2 (de) * 1988-12-27 1996-07-25 Lepetit Spa Chemisches Verfahren zur Herstellung des Antibiotikums L 17392 (Deglukoteicoplanin) und dessen Salze
US5206834A (en) * 1989-10-14 1993-04-27 Mitsubishi Denki Kabushiki Kaisha Semiconductor memory device performing last in-first out operation and the method for controlling the same
DK0424051T3 (da) * 1989-10-16 1995-02-27 Lilly Co Eli Glycopeptid-antibiotika
US5224972A (en) * 1990-09-11 1993-07-06 Frye Gregory C Coatings with controlled porosity and chemical properties
WO1992010516A1 (en) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
JP3314930B2 (ja) 1991-03-27 2002-08-19 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ 抗生物質ａ４０９２６エステル誘導体
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
CN1036654C (zh) * 1993-01-01 1997-12-10 格鲁波莱佩蒂特公司 抗菌素a40926的酰氨衍生物及其制备方法
DE69633234T2 (de) * 1995-07-05 2005-09-15 Aventis Bulk S.P.A. Reinigung von dalbeheptide-antibiotika mittels isoelektrofokussierung
KR20000010589A (ko) 1996-04-23 2000-02-15 클라우디오 쿼르타 항생제a40926의아미드유도체의개선된화학적제조방법
US7119061B2 (en) 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003299561A1 (en) * 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
JP5852880B2 (ja) * 2011-12-28 2016-02-03 国立研究開発法人国立循環器病研究センター 温度感応性材料
US20220204551A1 (en) * 2019-04-30 2022-06-30 Huvepharma Italia S.R.L. Method for the purification of lipoglycopeptide antibiotics
KR102467772B1 (ko) 2022-08-23 2022-11-16 최세근 디자인에 따라 결합 가능한 모듈이 구비된 신발

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521335A (en) * 1983-07-13 1985-06-04 Smithkline Beckman Corporation Aglycone and pseudo-aglycones of the AAD 216 antibiotics
GB8425685D0 (en) * 1984-10-11 1984-11-14 Lepetit Spa Antibiotic a 40926 complex

Also Published As

Publication number Publication date
EP0228015A3 (en) 1987-12-16
DK617086D0 (da) 1986-12-19
KR950010460B1 (ko) 1995-09-18
JP2514942B2 (ja) 1996-07-10
KR960010556B1 (ko) 1996-08-02
HU201099B (en) 1990-09-28
IL81105A (en) 1991-09-16
DE3683266D1 (de) 1992-02-13
ZA869716B (en) 1987-10-28
DK617086A (da) 1987-07-01
GR3003514T3 (es) 1993-03-16
ATE71113T1 (de) 1992-01-15
IE863381L (en) 1987-06-30
IL81105A0 (en) 1987-03-31
GB8531846D0 (en) 1986-02-05
HUT43091A (en) 1987-09-28
EP0228015B1 (en) 1992-01-02
JPS62175499A (ja) 1987-08-01
DK167815B1 (da) 1993-12-20
IE59603B1 (en) 1994-03-09
US4782042A (en) 1988-11-01
KR870006193A (ko) 1987-07-09
KR890002230A (ko) 1989-04-08
EP0228015A2 (en) 1987-07-08

Similar Documents

Publication Publication Date Title
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
DE3679908D1 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
ES2108371T3 (es) Nuevos derivados de estradieno de 11-benzaldoxima, procedimientos para su produccion y farmacos conteniendo estos compuestos.
ES2071351T3 (es) Un procedimiento para la produccion de 6,12-dihidro-6-hidroxicannabidiol y el uso del mismo para la produccion de trans-delta-9-tetrahidrocannabinol.
ES2037243T3 (es) Tiazolidindionas como agentes hipoglicemicos y anti-ateroscleroticos.
ES2121888T3 (es) Derivados iminicos ciclicos, procedimientos para su preparacion y medicamentos que contienen a estos compuestos.
ES2136725T3 (es) Utilizacion de 2-amino-6-n-propil-amino-4,5,6,7-tetrahidrobenzotiazol (pramipexol) como medicamento con efecto antidepresivo.
ES271886U (es) Dispositivo de maquillaje.
ES2040207T3 (es) Un procedimiento para preparar una sustancia antibiotica.
ES8900007A1 (es) Un metodo para producir normas orales frente a virus de hepatitis-b.
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
MX9303123A (es) Ciclopentano-y-penteno-beta-aminoacidos, procedimiento para su preparacion y medicamentos que los contienen.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ES2118728T3 (es) Procedimiento para la preparacion de 2,3-piridindicarboxilatos sustituidos y no sustituidos a partir de cloromaleato o clorofumarato o sus mezclas.
ES2105285T3 (es) Nuevos derivados de la adenosina, sus procedimientos de preparacion, composiciones farmaceuticas que los contienen.
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES2081476T3 (es) Uso de acidos grasos especificos en la fabricacion de un medicamento para su suministro por iontoforesis.
ES2019554A6 (es) Procedimiento para preparar n,n -ditrimetoxibenzoilpiperazinas sustituidas en posicion 2"
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
ES2021515A6 (es) Procedimiento para la preparacion de compuestos derivados de isotiazolo-piridona azetidinil substituidos.
CO4700299A1 (es) Derivados de piperazina, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion
ES2078501T3 (es) Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo.
ES2022865B3 (es) Compuestos azoicos que contienen grupos ciano, procedimientos para su obtencion y aplicacion de los mismos como colorantes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 228015

Country of ref document: ES